Vaccines Market Statistics

Nicole green

Nicole green

— 3 min read

The global vaccines market is experiencing significant growth, driven by factors such as increasing awareness of immunization, advancements in vaccine technology, and rising prevalence of infectious diseases. Below is a detailed overview of the market's current status and future outlook:

Market Size and Growth

  • The global vaccines market is projected to reach USD 86.81 billion in 2025, growing from USD 82.96 billion in 2024, with a compound annual growth rate (CAGR) of approximately 5.9% from 2025 to 2037. By 2037, the market is expected to reach USD 171.11 billion[1].
  • Other estimates suggest the market will grow from USD 87.57 billion in 2024 to USD 159.28 billion by 2032, at a CAGR of 7.8% during this period[2].
  • Preventive vaccines alone are expected to reach USD 90.78 billion in 2025, growing modestly at a CAGR of 1.42% to reach USD 97.41 billion by 2030[12].

Key Market Segments

  1. By Disease Type:
    • Viral Diseases: Includes vaccines for influenza, hepatitis, rubella, and rotavirus.
    • Bacterial Diseases: Includes vaccines for diphtheria, meningococcal infections, and pneumococcal diseases[1].
  2. By Technology:
    • Conjugate vaccines dominate the market due to their effectiveness against pathogens like meningitis and pneumonia.
    • mRNA vaccines are the fastest-growing segment due to advancements in immunotherapy platforms[2][7].
  3. By Patient Group:
    • Pediatric vaccines are growing rapidly, with a projected market size of USD 51.56 billion in 2025, driven by increasing prevalence of chronic diseases among children[4].
    • Adult vaccines accounted for approximately 57.25% of the market in 2023 due to widespread use of COVID-19 and influenza vaccinations[5].

Regional Insights

  • North America: Dominates the global market with advanced healthcare infrastructure and strong government support for immunization programs[7][10].
  • Asia-Pacific: Expected to witness the highest growth rate due to rising population, increasing awareness about vaccination, and government initiatives for immunization[1][10].
  • Europe: Shows steady growth with high vaccination coverage driven by mandatory immunization policies and robust healthcare systems[2].

Market Drivers

  • Increasing prevalence of infectious diseases such as COVID-19, influenza, and bacterial infections.
  • Technological advancements in vaccine development, including recombinant DNA technology and mRNA platforms.
  • Growing government initiatives and funding for immunization programs globally.
  • Rising demand for innovative delivery systems like oral vaccines[2][7].

Challenges

  • High costs associated with vaccine development (up to USD 1 billion per vaccine).
  • Regulatory hurdles that vary across regions.
  • Limited access to vaccines in low-income countries[7][13].

Key Players

Major companies driving the market include Pfizer Inc., Sanofi, GlaxoSmithKline plc, Merck & Co., Moderna Inc., and Johnson & Johnson. These companies focus on research and development (R&D) for new vaccine approvals and launches to maintain their competitive edge[2][10].

  • Development of combination vaccines to address multiple diseases simultaneously.
  • Expansion of therapeutic vaccines targeting cancer and other chronic conditions.
  • Increased adoption of artificial intelligence (AI) in vaccine manufacturing to streamline production processes[4][8].

In conclusion, the global vaccines market is poised for robust growth over the next decade, fueled by technological innovations, increasing disease burden, and supportive government policies worldwide. The Asia-Pacific region is expected to emerge as a key growth driver due to its large population base and growing healthcare investments.

Citations: [1] https://www.researchnester.com/reports/vaccines-market/1399 [2] https://www.fortunebusinessinsights.com/industry-reports/vaccines-market-101769 [3] https://www.globenewswire.com/news-release/2025/01/15/3009869/0/en/Dog-Vaccines-Market-Growth-Trends-Outlook-2025-2030-Rising-Pet-Humanization-Fuels-Demand-for-Dog-Vaccines-Driving-2-88-Billion-Market-Growth.html [4] https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report [5] https://www.grandviewresearch.com/industry-analysis/vaccine-market [6] https://www.thebusinessresearchcompany.com/report/conjugate-vaccine-global-market-report [7] https://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html [8] https://www.globenewswire.com/news-release/2025/01/14/3009526/0/en/Cancer-Vaccines-Market-Global-Forecast-to-2032-National-Immunization-Programs-Biotechnology-Innovations-to-Drive-Market-Growth.html [9] https://www.polarismarketresearch.com/industry-analysis/vaccine-adjuvants-market [10] https://www.meticulousresearch.com/product/vaccines-market-5076 [11] https://www.globenewswire.com/news-release/2025/01/16/3010565/0/en/United-States-Influenza-Vaccines-Market-Research-2025-Featuring-Sanofi-Pasteur-GSK-Seqirus-AstraZeneca-Size-Shares-Data-Latest-Trends-Insights-Growth-Potential-CAGR-Forecasts-to-20.html [12] https://www.mordorintelligence.com/industry-reports/preventive-vaccines-market [13] https://www.who.int/publications/m/item/global-vaccine-market-report-2024 [14] https://www.skyquestt.com/report/vaccines-market

Read more